Market Place
Sourcing Support
All News #Library
Others
Apogee Therapeutics To Participate In Upcoming March Conferences
24 Feb 2026 //
GLOBENEWSWIRE
Apogee Therapeutics at Jefferies Global Healthcare Conference
29 May 2025 //
GLOBENEWSWIRE
Apogee Therapeutics at Bank of America 2025 Health Care Conf.
01 May 2025 //
GLOBENEWSWIRE
Apogee Ph1 APG990 Shows Potential For 3- & 6-Month Maintenance
03 Mar 2025 //
GLOBENEWSWIRE
Apogee Reports FY24 Results, Highlights Pipeline Progress
03 Mar 2025 //
GLOBENEWSWIRE
Apogee Therapeutics to Join March Investor Conferences
25 Feb 2025 //
GLOBENEWSWIRE
Apogee Highlights Pipeline, Reports Q1 2024 Results
13 May 2024 //
GLOBENEWSWIRE
Apogee Therapeutics Announces First Participants Dosed in Ph1 Trial of APG808
25 Mar 2024 //
GLOBENEWSWIRE
Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering
12 Mar 2024 //
GLOBENEWSWIRE
Apogee Announces Pricing of Upsized $420 Million Underwritten Public Offering
07 Mar 2024 //
PRESS RELEASE
Apogee Catapults 42% After Eczema Drug Blows Expectations Out Of The Water
06 Mar 2024 //
YAHOO FINANCE
Apogee Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
05 Mar 2024 //
GLOBENEWSWIRE
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
05 Mar 2024 //
GLOBENEWSWIRE
Apogee to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777
04 Mar 2024 //
GLOBENEWSWIRE
Apogee Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Apogee Highlights Corporate Progress and Reports 2Q 2023 FYR
28 Aug 2023 //
GLOBENEWSWIRE
Apogee and Sagimet help crack open a stuck window on Wall Street
13 Jul 2023 //
ENDPTS
Apogee and Sagimet’s IPO plans come into view, with targeted raises of $228M
10 Jul 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.